Projects

Assessment of risks associated in the analytical phase in the clinical biochemistry laboratory in a tertiary care hospital in South India.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - 2025

Project Lead

Mr Santhosh M

Authors

Mr Santhosh M, Dr Jyothi D N, Dr Vinod George Thykadavil

Project Status

completed

Project Type

Student Project